Bioadaptives, Inc. Common (BDPT)
BDPT moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How BDPT actually reacts to news — the realized, point-in-time move the market made, measured across 77 labeled events over the last three years with zero look-ahead.
BDPT’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 19% | 63 |
| 30-min | 0.00% | 23% | 65 |
| 60-min | 0.00% | 23% | 65 |
| to close | 0.00% | 27% | 68 |
| Middle 50% of BDPT reactions | -10.00% to 0.00% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 77 |
Half of all Bioadaptives, Inc. Common news events land between -10.00% and +0.00% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when BDPT moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BDPT's baseline. Nothing else.
Recent BDPT events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| BioAdaptives Highlights Michael Bisping's MyndMed(TM) Routine in UFC 331 Pre-Show Instagram Video | Press release | ACCESS Newswire | +4.54% | +13.64% | |
| BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress | Press release | ACCESS Newswire | +0.00% | +0.00% | |
| UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM) | Press release | ACCESS Newswire | -3.57% | -7.14% | |
| BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update | Press release | ACCESS Newswire | +0.00% | -17.75% | |
| BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal | Press release | ACCESS Newswire | +17.65% | -5.88% | |
| BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform | Press release | ACCESS Newswire | -26.92% | -44.23% | |
| BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula | Press release | ACCESS Newswire | +13.85% | -30.77% | |
| BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor | Press release | ACCESS Newswire | +19.05% | +66.67% | |
| BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform | Press release | ACCESS Newswire | — | +0.00% | |
| Form 10-Q BIOADAPTIVES, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -30.00% | |
| Form 10-Q BIOADAPTIVES, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | +0.00% | |
| Form 10-Q BIOADAPTIVES, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +23.80% | |
| Form 10-K BIOADAPTIVES, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +7.02% | |
| Form NT 10-K BIOADAPTIVES, INC. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +39.92% | |
| Form DEF 14C BIOADAPTIVES, INC. For: Mar 28 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +40.06% | |
| Form 8-K BIOADAPTIVES, INC. For: Mar 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form DEF 14C BIOADAPTIVES, INC. For: Mar 14 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -0.08% | |
| Form SEC STAFF ACTION BIOADAPTIVES, INC. | SEC filing · Form SEC | SEC EDGAR | — | +2.79% | |
| Form 8-K BIOADAPTIVES, INC. For: Feb 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.53% | |
| Form 8-K BIOADAPTIVES, INC. For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K BIOADAPTIVES, INC. For: Nov 26 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| BioAdaptives, Inc. Announces Institutional Review Board Approval of a Human Clinical Trial for Zeranovia™ | Press release | GlobeNewswire | — | — | |
| BioAdaptives, Inc. Announces 5 Unique Products Ready for Phased Entry Into the Nutritional Marketplace | Press release | GlobeNewswire | — | — | |
| Form 8-K BIOADAPTIVES, INC. For: May 20 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q BIOADAPTIVES, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -20.00% | |
| Form NT 10-Q BIOADAPTIVES, INC. For: Sep 30 | SEC filing · Form NT | SEC EDGAR | +0.00% | +0.00% | |
| BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions | Press release | GlobeNewswire | -16.67% | +0.00% | |
| Form 8-K BIOADAPTIVES, INC. For: Oct 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| BioAdaptives, Inc. Letter to Shareholders Regarding the Reverse Stock Split | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form 10-Q BIOADAPTIVES, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form NT 10-Q BIOADAPTIVES, INC. For: Jun 30 | SEC filing · Form NT | SEC EDGAR | — | +0.00% | |
| BioAdaptives, Inc. Welcomes Gimhana Dissanayake to Its Board of Directors | Press release | GlobeNewswire | +16.67% | +0.00% | |
| Form 8-K BIOADAPTIVES, INC. For: May 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -14.29% | |
| Form 10-Q BIOADAPTIVES, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +25.00% | +25.00% | |
| Form NT 10-Q BIOADAPTIVES, INC. For: Mar 31 | SEC filing · Form NT | SEC EDGAR | +0.00% | +11.11% | |
| Form 8-K BIOADAPTIVES, INC. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-K BIOADAPTIVES, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | -16.67% | |
| Form NT 10-K BIOADAPTIVES, INC. For: Dec 31 | SEC filing · Form NT | SEC EDGAR | -25.00% | -25.00% | |
| BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System | Press release | GlobeNewswire | +0.00% | +0.00% | |
| BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management | Press release | GlobeNewswire | -21.43% | -42.86% | |
| BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System | Press release | GlobeNewswire | +0.00% | +20.00% | |
| Livestock Impact, Inc., Subsidiary of BioAdaptives, Inc., Launches Innovative Food Lab for Development of Treats and Supplement Powder for Human, Equine, and Canine Products | Press release | GlobeNewswire | -9.09% | -9.09% | |
| BioAdaptives, Inc. to Form New Division, AI BodyShape Lab, to Promote Adult Fitness and Weight Management | Press release | GlobeNewswire | +0.00% | -14.29% | |
| BioAdaptives, Inc. Introduces PROTEINnMORETM Ahead of 2024 Launch of AI-based “Fit Your Outfit” app | Press release | GlobeNewswire | +0.00% | -14.29% | |
| BioAdaptives Announces Special Holiday Wellness Offers and Gift | Press release | GlobeNewswire | +0.00% | +0.00% | |
| BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula | Press release | GlobeNewswire | -4.25% | -4.25% | |
| Form 10-Q BIOADAPTIVES, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -10.00% | +0.00% | |
| BioAdaptives Highlights Continued Success of Popular LUNG ARMOR™ System as US Enters Flu Season | Press release | GlobeNewswire | +0.00% | +9.09% | |
| BioAdaptives Takes Aim at Safe Pain Management with All-Natural Supplement | Press release | GlobeNewswire | +0.00% | +30.00% | |
| BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ™ Natural Supplement | Press release | GlobeNewswire | +0.00% | -8.33% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BDPT section they belong to.
Where else BDPT is measured.
BDPT earnings → · Analyst actions → · SEC filings →
Other Industrials names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RIGHTSCORP INC (RIHT) | 78 | 0.00% | 35% |
| ALFA-LAVAL AB UNSP/ADR (ALFVY) | 77 | 0.00% | 43% |
| StealthGas, Inc. - common stock (GASS) | 77 | -0.13% | 41% |
| ARCADIS NV S/ADR (ARCAY) | 76 | 0.00% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Industrials names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bioadaptives, Inc. Common's median reaction calculated?
Every labeled BDPT news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 77 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 23% of BDPT's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BDPT's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.